Monday, 29 September 2014

Drug Gives Big Survival Boost Against Type of Advanced Breast Cancer

White women overestimated their odds while other

Women with HER2-positive tumors gained an average 16 more months of life with Perjeta, study finds






from WebMD Health http://ift.tt/1ortv83

No comments:

Post a Comment